Atopic

India
Pharmaceutical manufacturing and distribution focused on medicines and health solutions in India.

About Atopic

Atopic is a Healthcare company based in India. Pharmaceutical manufacturing and distribution focused on medicines and health solutions in India. Its Indian entity Atopic Laboratories Private Limited reported revenue of β‚Ή25.88 Cr. Atopic offers products and services including Pediatric Products and Dermatology Products. Its focus areas include Pharmaceuticals, Drug Manufacturing, Medicines Production and Research and Development.

Company details

Atopic Laboratories Pvt. Ltd. is identified as a company that applies science and resources to enhance global health, with access to safe and affordable medicines being ensured through ethical practices and RD investments. Products are developed for various therapeutic areas, including pediatrics and dermatology, to improve well-being at all life stages. Patient safety and respect for people are prioritized, while innovations are implemented to address pressing health challenges, all conducted transparently and responsibly.

Key Metrics
  • Annual Revenue
    ₹25.88 Cr

    FY 2025 · +37% YoY

  • Net Profit
    ₹12 Lakh

    FY 2025 · 0% margin

  • EBITDA
    ₹42.9 Lakh

    FY 2025 · 2% margin

Products & Services of Atopic

Atopic offers a comprehensive portfolio of products and services, including Pediatric Products and Dermatology Products.

Pediatric Products
Pharmaceuticals

Products for children's health are manufactured and distributed to support treatment and prevention.

Dermatology Products
Pharmaceuticals

Medicines for skin conditions are developed and provided across various therapeutic needs.

Board of directors of Atopic Laboratories Private Limited (Atopic)

Atopic Laboratories Private Limited is the primary company behind Atopic. The board of Atopic Laboratories Private Limited currently have 3 directors; the longest-serving is Kaushal Bhupendra Patel, appointed in 2004. 2 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Kaushal Bhupendra Patel
DIN 00240628
Director29 Mar 200422 yrs 7 moAtopic Laboratories Private Limited
Rakeshbhai Ishwarbhai Patel
DIN 00192390
Director29 Mar 200422 yrs 7 moAtopic Laboratories Private Limited
Bhupendra Ishwerbhai Patel
DIN 00192203
Director29 Mar 200422 yrs 7 moAtopic Laboratories Private Limited

Financials of Atopic

Figures of Atopic Laboratories Private Limited, the primary company behind Atopic, for FY 2025. Revenue was ₹25.88 Cr (+37% year on year). Net profit was ₹12 Lakh (0% margin). EBITDA was ₹42.9 Lakh (2% margin). Revenue has grown at a compounded annual rate of +24% over three years and +14% over five years.

  • ₹25.88 CrRevenue · FY 2025 · +37% YoY
  • ₹12 LakhNet profit · 0% margin
  • ₹42.9 LakhEBITDA · 2% margin
  • ₹1 LakhPaid-up capital
  • +24%Revenue CAGR, 3 years
  • +14%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Atopic Laboratories Private Limited are on its company page.

Premium access

Detailed financial statements for Atopic

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Atopic

Atopic is headquartered in India.

The primary company behind Atopic, Atopic Laboratories Private Limited, reported revenue of β‚Ή25.88 Cr for FY 2025, up 37% year on year.

Atopic Laboratories Pvt. Ltd. is identified as a company that applies science and resources to enhance global health, with access to safe and affordable medicines being ensured through ethical practices and RD investments. Products are developed for various therapeutic areas, including pediatrics and dermatology, to improve well-being at all life stages. Patient safety and respect for people are prioritized, while innovations are implemented to address pressing health challenges, all conducted transparently and responsibly.

Atopic offers Pediatric Products and Dermatology Products.

Atopic operates through Atopic Laboratories Private Limited.

The legal entities of Atopic currently have 3 directors, including Kaushal Bhupendra Patel, Rakeshbhai Ishwarbhai Patel, Bhupendra Ishwerbhai Patel.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available